Sarahi J. Hernández-Reyes, Unidad de Medicina Familiar 9, IMSS, Santiago de Querétaro, Qro., México
Iris Pineda-Mújica, Unidad de Medicina Familiar 13, IMSS, Santiago de Querétaro, Qro., México
Lilia S. Gallardo-Vidal, Unidad de Medicina Familiar 13, IMSS, Santiago de Querétaro, Qro., México
Adriana J. Rodríguez-Méndez, Facultad de Medicina, Universidad Autónoma de Querétaro, Santiago de Querétaro, Qro., México
Ma. Fernanda Aguilar-Etchegaray, Unidad de Medicina Familiar 13, IMSS, Santiago de Querétaro, Qro., México
Jacqueline Jiménez-Avila, Unidad de Medicina Familiar 13, IMSS, Santiago de Querétaro, Qro., México
Background: The side effects of breast cancer treatment reduce therapeutic adherence, resulting in increased recurrence, progression and mortality, and the way the patient copes may be associated with this adherence. Objective: To determine the association between coping strategies and adherence to the treatment in patients with breast cancer. Method: Association design in women with breast cancer treated in the oncology service with and without therapeutic adherence (n = 40 per group). The Morisky-Green test was applied to evaluate therapeutic adherence and the Coping Strategies Inventory (CSI). The results were analyzed using the Chi-square test, odds ratio (OR), logistic regression analysis, and risk probability analysis for therapeutic non-adherence. Results: Adaptive coping strategies were those with the highest strength of association for therapeutic adherence (p < 0.05). These were incorporated into a logistic regression analysis (p < 0.000), and 97% probability of therapeutic non-adherence was obtained in those patients who do not face the disease in an adaptive way. Conclusions: Adaptive coping strategies promote therapeutic adherence to breast cancer.
Keywords: Coping strategies. Therapeutic adherence. Breast cancer.
